SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009419
Filing Date
2018-11-19
Accepted
2018-11-19 14:25:00
Documents
80
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20180930x10q.htm 10-Q 2854797
2 EX-31.1 jagx-20180930ex31145c395.htm EX-31.1 12635
3 EX-31.2 jagx-20180930ex3125aa997.htm EX-31.2 12624
4 EX-32.1 jagx-20180930ex321c62021.htm EX-32.1 7928
5 EX-32.2 jagx-20180930ex322d94b6b.htm EX-32.2 7922
  Complete submission text file 0001558370-18-009419.txt   10887490

Data Files

Seq Description Document Type Size
6 EX-101.INS jagx-20180930.xml EX-101.INS 2207611
7 EX-101.SCH jagx-20180930.xsd EX-101.SCH 89056
8 EX-101.CAL jagx-20180930_cal.xml EX-101.CAL 76797
9 EX-101.DEF jagx-20180930_def.xml EX-101.DEF 440058
10 EX-101.LAB jagx-20180930_lab.xml EX-101.LAB 699933
11 EX-101.PRE jagx-20180930_pre.xml EX-101.PRE 602024
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 181192136
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1